Aclaris Therapeutics, Inc. - Common Stock —— 季度现金流量表 (NASDAQ:ACRS) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

总资产 220.33 M198.09 M189.15 M175.53 M160.46 M198.72 M 负债总额 64.77 M54.03 M57.41 M55.43 M57.38 M55.07 M 权益总额 155.55 M144.07 M131.74 M120.1 M103.08 M143.65 M 负债及股东权益总额 220.33 M198.09 M189.15 M175.53 M160.46 M198.72 M 总债务 —————— 净债务 ——————

新闻

Aclaris Therapeutics (ACRS) Reports Q1 Loss, Beats Revenue Estimates

Rigel Pharmaceuticals (RIGL) Lags Q1 Earnings and Revenue Estimates

Aclaris Therapeutics, Inc. (ACRS) Discusses Clinical Program Update and Progress of Lead Bispecific Antibody Candidates - Slideshow (NASDAQ:ACRS) 2026-04-28

Profound Medical (PROF) Surges 13.0%: Is This an Indication of Further Gains?

H.C. Wainwright维持Aclaris Therapeutics买入评级

Aclaris Therapeutics stock rating reiterated at Buy by H.C. Wainwright

Stifel因管线前景上调Aclaris Therapeutics目标价至3美元

Stifel raises Aclaris Therapeutics stock price target to $3 on pipeline

Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates

Aclaris TherapeuticsQ4每股收益及营收逊于预期

Aclaris Therapeutics Inc earnings missed by $0.01, revenue fell short of estimates

Ionis Pharmaceuticals (IONS) Reports Q4 Loss, Tops Revenue Estimates